25 XP   0   0   10

Gritstone Oncology Inc
Buy, Hold or Sell?

Let's analyse Gritstone Oncology Inc together

PenkeI guess you are interested in Gritstone Oncology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gritstone Oncology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gritstone Oncology Inc

I send you an email if I find something interesting about Gritstone Oncology Inc.

Quick analysis of Gritstone Oncology Inc (30 sec.)










What can you expect buying and holding a share of Gritstone Oncology Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.01
When do you have the money?
1 year
How often do you get paid?
7.1%

What is your share worth?

Current worth
$0.53
Expected worth in 1 year
$-0.68
How sure are you?
32.1%

+ What do you gain per year?

Total Gains per Share
$-1.20
Return On Investment
-161.2%

For what price can you sell your share?

Current Price per Share
$0.74
Expected price per share
$0 - $1.47
How sure are you?
50%

1. Valuation of Gritstone Oncology Inc (5 min.)




Live pricePrice per Share (EOD)

$0.74

Intrinsic Value Per Share

$-12.07 - $-14.09

Total Value Per Share

$-11.54 - $-13.56

2. Growth of Gritstone Oncology Inc (5 min.)




Is Gritstone Oncology Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$51.8m$165m-$70.9m-75.5%

How much money is Gritstone Oncology Inc making?

Current yearPrevious yearGrowGrow %
Making money-$34.6m-$29.6m-$4.9m-14.3%
Net Profit Margin-30,952.6%-2,717.3%--

How much money comes from the company's main activities?

3. Financial Health of Gritstone Oncology Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#474 / 1016

Most Revenue
#536 / 1016

Most Profit
#827 / 1016

Most Efficient
#982 / 1016

What can you expect buying and holding a share of Gritstone Oncology Inc? (5 min.)

Welcome investor! Gritstone Oncology Inc's management wants to use your money to grow the business. In return you get a share of Gritstone Oncology Inc.

What can you expect buying and holding a share of Gritstone Oncology Inc?

First you should know what it really means to hold a share of Gritstone Oncology Inc. And how you can make/lose money.

Speculation

The Price per Share of Gritstone Oncology Inc is $0.7437. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gritstone Oncology Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gritstone Oncology Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.53. Based on the TTM, the Book Value Change Per Share is $-0.30 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gritstone Oncology Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.31-42.3%-0.31-42.1%-0.31-41.0%-0.26-35.5%-0.24-32.1%
Usd Book Value Change Per Share-0.11-15.2%-0.30-40.8%-0.12-15.5%-0.05-6.7%0.022.5%
Usd Dividend Per Share0.011.0%0.000.5%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.11-14.1%-0.30-40.3%-0.12-15.5%-0.05-6.6%0.022.6%
Usd Price Per Share2.04-2.12-3.14-6.22-5.50-
Price to Earnings Ratio-1.62--1.71--2.58--4.07--4.35-
Price-to-Total Gains Ratio-19.41--9.36--5.94--4.18--13.51-
Price to Book Ratio3.86-2.71-1.85-4.21-4.06-
Price-to-Total Gains Ratio-19.41--9.36--5.94--4.18--13.51-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7437
Number of shares1344
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.30-0.05
Usd Total Gains Per Share-0.30-0.05
Gains per Quarter (1344 shares)-402.77-65.71
Gains per Year (1344 shares)-1,611.08-262.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
119-1630-16214-267-273
238-3260-32328-533-536
357-4890-484311-800-799
476-6520-645415-1066-1062
594-8150-806519-1333-1325
6113-9780-967623-1600-1588
7132-11410-1128726-1866-1851
8151-13040-1289830-2133-2114
9170-14670-1450934-2400-2377
10189-16300-1612038-2666-2640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.027.00.03.6%1.027.00.03.6%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%6.014.00.030.0%9.016.03.032.1%9.016.03.032.1%
Dividend per Share2.00.02.050.0%2.00.010.016.7%2.00.018.010.0%2.00.026.07.1%2.00.026.07.1%
Total Gains per Share0.04.00.00.0%4.08.00.033.3%6.014.00.030.0%9.016.03.032.1%9.016.03.032.1%

Fundamentals of Gritstone Oncology Inc

About Gritstone Oncology Inc

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors. The company is also developing SLATE, an off-the-shelf immunotherapy candidate, which is in Phase 2 clinical trials for the treatment of metastatic solid tumors. In addition, it develops CORAL, a COVID-19 vaccine program; and a therapeutic vaccine candidate that is in Phase 1 clinical trials designed to treat and cure human immunodeficiency virus (HIV) infection. Gritstone bio, Inc. has a strategic collaboration with bluebird bio, Inc.; collaboration agreement with Gilead Sciences, Inc.; and license agreement with Genevant Sciences GmbH. The company was formerly known as Gritstone Oncology, Inc. and changed its name to Gritstone bio, Inc. in May 2021. Gritstone bio, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Fundamental data was last updated by Penke on 2024-04-11 10:20:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gritstone Oncology Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gritstone Oncology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -106,269.0% means that $-1,062.69 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gritstone Oncology Inc:

  • The MRQ is -106,269.0%. The company is making a huge loss. -2
  • The TTM is -30,952.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-106,269.0%TTM-30,952.6%-75,316.4%
TTM-30,952.6%YOY-2,717.3%-28,235.3%
TTM-30,952.6%5Y-7,983.3%-22,969.3%
5Y-7,983.3%10Y-6,450.6%-1,532.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-106,269.0%-197.2%-106,071.8%
TTM-30,952.6%-210.4%-30,742.2%
YOY-2,717.3%-279.3%-2,438.0%
5Y-7,983.3%-436.8%-7,546.5%
10Y-6,450.6%-599.3%-5,851.3%
1.1.2. Return on Assets

Shows how efficient Gritstone Oncology Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • -17.3% Return on Assets means that Gritstone Oncology Inc generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gritstone Oncology Inc:

  • The MRQ is -17.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.3%TTM-17.5%+0.1%
TTM-17.5%YOY-13.2%-4.3%
TTM-17.5%5Y-13.3%-4.1%
5Y-13.3%10Y-14.8%+1.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.3%-13.6%-3.7%
TTM-17.5%-12.9%-4.6%
YOY-13.2%-11.9%-1.3%
5Y-13.3%-14.2%+0.9%
10Y-14.8%-16.2%+1.4%
1.1.3. Return on Equity

Shows how efficient Gritstone Oncology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • -59.4% Return on Equity means Gritstone Oncology Inc generated $-0.59 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gritstone Oncology Inc:

  • The MRQ is -59.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.4%TTM-41.9%-17.5%
TTM-41.9%YOY-18.3%-23.7%
TTM-41.9%5Y-22.2%-19.7%
5Y-22.2%10Y-20.9%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.4%-17.0%-42.4%
TTM-41.9%-16.1%-25.8%
YOY-18.3%-15.4%-2.9%
5Y-22.2%-20.0%-2.2%
10Y-20.9%-21.1%+0.2%

1.2. Operating Efficiency of Gritstone Oncology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gritstone Oncology Inc is operating .

  • Measures how much profit Gritstone Oncology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • An Operating Margin of -140,775.9% means the company generated $-1,407.76  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gritstone Oncology Inc:

  • The MRQ is -140,775.9%. The company is operating very inefficient. -2
  • The TTM is -39,589.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-140,775.9%TTM-39,589.9%-101,186.0%
TTM-39,589.9%YOY-2,735.7%-36,854.2%
TTM-39,589.9%5Y-9,734.9%-29,855.0%
5Y-9,734.9%10Y-7,705.0%-2,029.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-140,775.9%-286.1%-140,489.8%
TTM-39,589.9%-224.4%-39,365.5%
YOY-2,735.7%-288.4%-2,447.3%
5Y-9,734.9%-475.2%-9,259.7%
10Y-7,705.0%-624.7%-7,080.3%
1.2.2. Operating Ratio

Measures how efficient Gritstone Oncology Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1,408.76 means that the operating costs are $1,408.76 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Gritstone Oncology Inc:

  • The MRQ is 1,408.759. The company is inefficient in keeping operating costs low. -1
  • The TTM is 412.903. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1,408.759TTM412.903+995.855
TTM412.903YOY31.509+381.394
TTM412.9035Y106.909+305.994
5Y106.90910Y90.261+16.648
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1,408.7592.997+1,405.762
TTM412.9033.247+409.656
YOY31.5093.766+27.743
5Y106.9095.675+101.234
10Y90.2617.857+82.404

1.3. Liquidity of Gritstone Oncology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gritstone Oncology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 3.20 means the company has $3.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Gritstone Oncology Inc:

  • The MRQ is 3.198. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.722. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.198TTM4.722-1.524
TTM4.722YOY5.161-0.439
TTM4.7225Y6.139-1.416
5Y6.13910Y6.860-0.722
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1983.930-0.732
TTM4.7224.251+0.471
YOY5.1615.436-0.275
5Y6.1396.045+0.094
10Y6.8606.363+0.497
1.3.2. Quick Ratio

Measures if Gritstone Oncology Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • A Quick Ratio of 3.59 means the company can pay off $3.59 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gritstone Oncology Inc:

  • The MRQ is 3.588. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.989. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.588TTM6.989-3.401
TTM6.989YOY7.510-0.521
TTM6.9895Y8.679-1.689
5Y8.67910Y8.838-0.159
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5883.629-0.041
TTM6.9894.065+2.924
YOY7.5105.397+2.113
5Y8.6795.993+2.686
10Y8.8386.277+2.561

1.4. Solvency of Gritstone Oncology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gritstone Oncology Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gritstone Oncology Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.71 means that Gritstone Oncology Inc assets are financed with 70.8% credit (debt) and the remaining percentage (100% - 70.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gritstone Oncology Inc:

  • The MRQ is 0.708. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.537. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.708TTM0.537+0.171
TTM0.537YOY0.271+0.267
TTM0.5375Y0.317+0.220
5Y0.31710Y0.277+0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7080.332+0.376
TTM0.5370.334+0.203
YOY0.2710.268+0.003
5Y0.3170.366-0.049
10Y0.2770.390-0.113
1.4.2. Debt to Equity Ratio

Measures if Gritstone Oncology Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 242.9% means that company has $2.43 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gritstone Oncology Inc:

  • The MRQ is 2.429. The company is just not able to pay all its debts with equity.
  • The TTM is 1.370. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ2.429TTM1.370+1.058
TTM1.370YOY0.376+0.994
TTM1.3705Y0.566+0.805
5Y0.56610Y0.457+0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4290.381+2.048
TTM1.3700.390+0.980
YOY0.3760.334+0.042
5Y0.5660.434+0.132
10Y0.4570.466-0.009

2. Market Valuation of Gritstone Oncology Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Gritstone Oncology Inc generates.

  • Above 15 is considered overpriced but always compare Gritstone Oncology Inc to the Biotechnology industry mean.
  • A PE ratio of -1.62 means the investor is paying $-1.62 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gritstone Oncology Inc:

  • The EOD is -0.592. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.623. Based on the earnings, the company is expensive. -2
  • The TTM is -1.711. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.592MRQ-1.623+1.031
MRQ-1.623TTM-1.711+0.088
TTM-1.711YOY-2.577+0.867
TTM-1.7115Y-4.065+2.355
5Y-4.06510Y-4.355+0.289
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.592-2.315+1.723
MRQ-1.623-2.560+0.937
TTM-1.711-2.664+0.953
YOY-2.577-4.122+1.545
5Y-4.065-6.258+2.193
10Y-4.355-6.108+1.753
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gritstone Oncology Inc:

  • The EOD is -0.527. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.447. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.653. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.527MRQ-1.447+0.919
MRQ-1.447TTM-1.653+0.206
TTM-1.653YOY-2.499+0.846
TTM-1.6535Y-4.690+3.037
5Y-4.69010Y4.787-9.477
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.527-3.067+2.540
MRQ-1.447-3.251+1.804
TTM-1.653-3.545+1.892
YOY-2.499-5.595+3.096
5Y-4.690-8.315+3.625
10Y4.787-8.708+13.495
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gritstone Oncology Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.86 means the investor is paying $3.86 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Gritstone Oncology Inc:

  • The EOD is 1.407. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.858. Based on the equity, the company is fair priced.
  • The TTM is 2.711. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.407MRQ3.858-2.452
MRQ3.858TTM2.711+1.147
TTM2.711YOY1.853+0.858
TTM2.7115Y4.214-1.503
5Y4.21410Y4.059+0.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4071.905-0.498
MRQ3.8582.111+1.747
TTM2.7112.095+0.616
YOY1.8532.836-0.983
5Y4.2143.443+0.771
10Y4.0593.794+0.265
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Gritstone Oncology Inc.

3.1. Institutions holding Gritstone Oncology Inc

Institutions are holding 43.602% of the shares of Gritstone Oncology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Redmile Group, LLC8.6770.69648509126164890024.0357
2023-09-30Point72 Asset Management, L.P.6.04170.02975924867-1648813-21.7703
2023-12-31BlackRock Inc5.98410.00035868353-219696-3.6086
2023-12-31Morgan Stanley - Brokerage Accounts5.62930.00155204533758212213.2632
2023-12-31Vanguard Group Inc4.50340.000244162923580758.8235
2023-12-31Versant Venture Management LLC3.63141.8683356115000
2023-12-31FMR Inc2.02450.000319852941131696132.5795
2023-12-31Geode Capital Management, LLC1.94340.000419057731386747.8476
2023-12-31State Street Corporation1.81610.0002178100318438611.5485
2023-12-31Ensign Peak Advisors Inc0.81360.003279788000
2023-12-31Northern Trust Corp0.74640.000373192287981.2167
2023-09-30Citadel Advisors Llc0.35970.0001352739-87609-19.8954
2023-12-31Nuveen Asset Management, LLC0.34720.0002340478-971-0.2844
2023-12-31Bank of New York Mellon Corp0.3330.00013265245374119.701
2023-12-31Goldman Sachs Group Inc0.27970.00012743088859747.7069
2023-12-31Charles Schwab Investment Management Inc0.27250.00012672056656533.1763
2023-12-31Panagora Asset Management Inc0.20540.0023201439-10350-4.8869
2023-12-31JANE STREET GROUP, LLC0.20490.00012009822009820
2023-12-31UBS Group AG0.20160.0001197668-68259-25.6683
2023-12-31Bridgeway Capital Management, LLC0.19770.008519390000
Total 44.21262.611943357356+5602928+12.9%

3.2. Funds holding Gritstone Oncology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.90240.0005284625600
2024-03-28iShares Russell 2000 ETF2.24650.0087220302810620.0482
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.31610.00351290634511114.1234
2024-01-31Fidelity Small Cap Index0.90580.0086888276115041.3121
2024-03-28iShares Russell 2000 Value ETF0.88370.0178866600415735.039
2024-02-29Fidelity Select Biotechnology0.86290.0482846176-1012500-54.4743
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.55560.003754490000
2024-02-29Fidelity Extended Market Index0.49320.0035483641-2343-0.4821
2024-03-31State St Russell Sm Cap® Indx SL Cl I0.32990.008532350000
2024-02-29Vanguard Russell 2000 ETF0.32130.0093315124249208.5871
2023-12-31NT R2000 Value Index Fund - NL0.24670.0131241919-2841-1.1607
2023-12-31NT R2000 Index Fund - NL0.24490.0068240204-2502-1.0309
2023-09-30BlackRock Extended Mkt Composite0.20890.002520481915360.7556
2024-02-29Schwab Small Cap Index0.20460.009520064000
2024-03-28iShares Micro-Cap ETF0.20260.055519867747782.4642
2023-12-31NT R2000 Index Fund - DC - NL - 20.19290.0068189163-2708-1.4114
2023-12-31Bridgeway Ultra-Small Company Market0.18650.200818290000
2024-03-31BlackRock Extended Equity Market K0.180.0031176479640.0363
2024-03-31Russell 2000 Index Non-Lendable Fund E0.17180.0084168507-1829-1.0738
2023-12-31Northern Trust Russell 2000 Value Index0.17180.0132168443138168.9351
Total 12.82810.43212579886-874359-7.0%

3.3. Insider Transactions

Insiders are holding 2.484% of the shares of Gritstone Oncology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-23Vassiliki EconomidesBUY120001.9

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Gritstone Oncology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.113-0.303+169%-0.115+2%-0.050-56%0.019-697%
Book Value Per Share--0.5290.839-37%1.683-69%1.452-64%1.256-58%
Current Ratio--3.1984.722-32%5.161-38%6.139-48%6.860-53%
Debt To Asset Ratio--0.7080.537+32%0.271+162%0.317+123%0.277+156%
Debt To Equity Ratio--2.4291.370+77%0.376+545%0.566+329%0.457+431%
Dividend Per Share--0.0080.004+115%-+100%0.001+977%0.001+1408%
Eps---0.314-0.3130%-0.305-3%-0.264-16%-0.239-24%
Free Cash Flow Per Share---0.352-0.320-9%-0.311-12%-0.254-28%-0.219-38%
Free Cash Flow To Equity Per Share---0.041-0.221+445%-0.099+143%-0.029-29%0.030-237%
Gross Profit Margin--0.9380.984-5%1.000-6%0.997-6%0.998-6%
Intrinsic Value_10Y_max---14.092--------
Intrinsic Value_10Y_min---12.072--------
Intrinsic Value_1Y_max---1.088--------
Intrinsic Value_1Y_min---1.069--------
Intrinsic Value_3Y_max---3.516--------
Intrinsic Value_3Y_min---3.352--------
Intrinsic Value_5Y_max---6.242--------
Intrinsic Value_5Y_min---5.773--------
Market Cap72931386.720-174%200053824.000235162907.053-15%307925984.000-35%615200151.411-67%543413239.008-63%
Net Profit Margin---1062.690-309.526-71%-27.173-97%-79.833-92%-64.506-94%
Operating Margin---1407.759-395.899-72%-27.357-98%-97.349-93%-77.050-95%
Operating Ratio--1408.759412.903+241%31.509+4371%106.909+1218%90.261+1461%
Pb Ratio1.407-174%3.8582.711+42%1.853+108%4.214-8%4.059-5%
Pe Ratio-0.592+64%-1.623-1.711+5%-2.577+59%-4.065+150%-4.355+168%
Price Per Share0.744-174%2.0402.123-4%3.140-35%6.218-67%5.502-63%
Price To Free Cash Flow Ratio-0.527+64%-1.447-1.653+14%-2.499+73%-4.690+224%4.787-130%
Price To Total Gains Ratio-7.075+64%-19.407-9.364-52%-5.936-69%-4.181-78%-13.513-30%
Quick Ratio--3.5886.989-49%7.510-52%8.679-59%8.838-59%
Return On Assets---0.173-0.175+1%-0.132-24%-0.133-23%-0.148-15%
Return On Equity---0.594-0.419-29%-0.183-69%-0.222-63%-0.209-65%
Total Gains Per Share---0.105-0.300+185%-0.115+10%-0.049-53%0.019-642%
Usd Book Value--51850000.00094069250.000-45%165049250.000-69%144718500.000-64%124852714.286-58%
Usd Book Value Change Per Share---0.113-0.303+169%-0.115+2%-0.050-56%0.019-697%
Usd Book Value Per Share--0.5290.839-37%1.683-69%1.452-64%1.256-58%
Usd Dividend Per Share--0.0080.004+115%-+100%0.001+977%0.001+1408%
Usd Eps---0.314-0.3130%-0.305-3%-0.264-16%-0.239-24%
Usd Free Cash Flow---34566000.000-35271750.000+2%-30454500.000-12%-25642350.000-26%-22038375.000-36%
Usd Free Cash Flow Per Share---0.352-0.320-9%-0.311-12%-0.254-28%-0.219-38%
Usd Free Cash Flow To Equity Per Share---0.041-0.221+445%-0.099+143%-0.029-29%0.030-237%
Usd Market Cap72931386.720-174%200053824.000235162907.053-15%307925984.000-35%615200151.411-67%543413239.008-63%
Usd Price Per Share0.744-174%2.0402.123-4%3.140-35%6.218-67%5.502-63%
Usd Profit---30818000.000-34625000.000+12%-29686750.000-4%-26603800.000-14%-23203553.571-25%
Usd Revenue--29000.000634000.000-95%2317250.000-99%3346250.000-99%2432571.429-99%
Usd Total Gains Per Share---0.105-0.300+185%-0.115+10%-0.049-53%0.019-642%
 EOD+3 -5MRQTTM+12 -24YOY+9 -275Y+4 -3210Y+5 -31

4.2. Fundamental Score

Let's check the fundamental score of Gritstone Oncology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.592
Price to Book Ratio (EOD)Between0-11.407
Net Profit Margin (MRQ)Greater than0-1,062.690
Operating Margin (MRQ)Greater than0-1,407.759
Quick Ratio (MRQ)Greater than13.588
Current Ratio (MRQ)Greater than13.198
Debt to Asset Ratio (MRQ)Less than10.708
Debt to Equity Ratio (MRQ)Less than12.429
Return on Equity (MRQ)Greater than0.15-0.594
Return on Assets (MRQ)Greater than0.05-0.173
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Gritstone Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.742
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -8028-52-73-12573-52553
Net Interest Income  629205834-340494-318176-519-343



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets177,769
Total Liabilities125,919
Total Stockholder Equity51,850
 As reported
Total Liabilities 125,919
Total Stockholder Equity+ 51,850
Total Assets = 177,769

Assets

Total Assets177,769
Total Current Assets87,435
Long-term Assets90,334
Total Current Assets
Cash And Cash Equivalents 65,285
Short-term Investments 16,288
Net Receivables 231
Other Current Assets 5,631
Total Current Assets  (as reported)87,435
Total Current Assets  (calculated)87,435
+/-0
Long-term Assets
Property Plant Equipment 84,120
Long-term Assets Other 924
Long-term Assets  (as reported)90,334
Long-term Assets  (calculated)85,044
+/- 5,290

Liabilities & Shareholders' Equity

Total Current Liabilities27,339
Long-term Liabilities98,580
Total Stockholder Equity51,850
Total Current Liabilities
Short-term Debt 6,904
Accounts payable 3,819
Other Current Liabilities 14,266
Total Current Liabilities  (as reported)27,339
Total Current Liabilities  (calculated)24,989
+/- 2,350
Long-term Liabilities
Long term Debt 40,144
Capital Lease Obligations Min Short Term Debt57,727
Long-term Liabilities Other 709
Long-term Liabilities  (as reported)98,580
Long-term Liabilities  (calculated)98,580
+/-0
Total Stockholder Equity
Common Stock22
Retained Earnings -659,561
Accumulated Other Comprehensive Income 3
Other Stockholders Equity 711,386
Total Stockholder Equity (as reported)51,850
Total Stockholder Equity (calculated)51,850
+/-0
Other
Capital Stock22
Cash and Short Term Investments 81,573
Common Stock Shares Outstanding 97,585
Current Deferred Revenue2,350
Liabilities and Stockholders Equity 177,769
Net Debt 39,490
Net Invested Capital 91,994
Net Working Capital 60,096
Property Plant and Equipment Gross 116,535
Short Long Term Debt Total 104,775



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-03-312016-12-31
> Total Assets 
46,421
0
0
117,300
95,951
95,951
113,201
189,558
175,487
228,180
208,651
184,389
163,018
145,666
122,508
221,567
246,939
224,224
271,282
278,106
243,472
213,953
205,242
240,754
209,952
222,623
187,217
177,769
177,769187,217222,623209,952240,754205,242213,953243,472278,106271,282224,224246,939221,567122,508145,666163,018184,389208,651228,180175,487189,558113,20195,95195,951117,3000046,421
   > Total Current Assets 
38,391
0
0
88,479
66,882
66,882
84,150
157,636
135,000
184,697
154,783
131,273
112,346
94,497
73,747
175,390
202,513
176,755
218,401
220,590
192,503
161,735
153,427
182,878
154,765
122,376
90,820
87,435
87,43590,820122,376154,765182,878153,427161,735192,503220,590218,401176,755202,513175,39073,74794,497112,346131,273154,783184,697135,000157,63684,15066,88266,88288,4790038,391
       Cash And Cash Equivalents 
12,410
0
0
39,007
37,541
37,541
65,936
52,183
34,572
107,728
116,942
57,408
54,860
62,631
57,648
170,056
108,505
64,081
131,423
93,287
69,158
65,694
64,909
55,498
47,128
41,414
29,539
65,285
65,28529,53941,41447,12855,49864,90965,69469,15893,287131,42364,081108,505170,05657,64862,63154,86057,408116,942107,72834,57252,18365,93637,54137,54139,0070012,410
       Short-term Investments 
25,097
0
0
46,946
26,949
26,949
11,486
100,927
97,590
73,511
32,523
70,368
54,020
29,282
12,897
1,002
89,501
107,101
68,255
108,346
103,004
78,939
74,900
116,389
98,680
73,119
54,409
16,288
16,28854,40973,11998,680116,38974,90078,939103,004108,34668,255107,10189,5011,00212,89729,28254,02070,36832,52373,51197,590100,92711,48626,94926,94946,9460025,097
       Net Receivables 
171
0
0
1,710
0
0
0
462
227
888
238
482
662
293
61
0
249
2,470
3,424
2,365
2,459
675
820
664
566
399
337
231
2313373995666648206752,4592,3653,4242,4702490612936624822388882274620001,71000171
       Other Current Assets 
713
0
0
95
0
2,392
904
449
500
389
807
290
367
290
403
268
513
336
814
866
990
790
796
567
6,880
718
824
5,631
5,6318247186,8805677967909908668143365132684032903672908073895004499042,39209500713
   > Long-term Assets 
0
0
0
28,821
0
29,069
29,051
31,922
40,487
43,483
53,868
53,116
50,672
51,169
48,761
46,177
44,426
47,469
52,881
57,516
50,969
52,218
51,815
57,876
55,187
100,247
96,397
90,334
90,33496,397100,24755,18757,87651,81552,21850,96957,51652,88147,46944,42646,17748,76151,16950,67253,11653,86843,48340,48731,92229,05129,069028,821000
       Property Plant Equipment 
7,490
0
0
27,211
27,533
27,533
27,012
29,494
37,670
40,275
49,156
50,338
47,977
48,490
46,012
43,449
41,690
40,492
45,130
44,542
44,115
43,838
40,993
38,816
35,980
92,428
89,861
84,120
84,12089,86192,42835,98038,81640,99343,83844,11544,54245,13040,49241,69043,44946,01248,49047,97750,33849,15640,27537,67029,49427,01227,53327,53327,211007,490
       Long Term Investments 
0
0
0
0
0
0
0
0
0
508
2,003
0
0
0
0
0
0
4,001
0
4,617
0
0
0
4,031
0
0
0
0
00004,0310004,61704,0010000002,003508000000000
       Intangible Assets 
0
0
0
0
0
0
415
554
554
553
516
585
502
469
539
518
519
0
0
0
0
0
0
0
0
0
0
0
00000000000519518539469502585516553554554415000000
       Long-term Assets Other 
0
0
0
1,610
0
1,536
1,624
1,874
2,263
1,092
992
2,193
2,193
2,210
2,210
2,210
2,217
2,976
7,751
8,357
6,854
3,090
5,532
15,029
13,917
2,529
1,246
924
9241,2462,52913,91715,0295,5323,0906,8548,3577,7512,9762,2172,2102,2102,2102,1932,1939921,0922,2631,8741,6241,53601,610000
> Total Liabilities 
4,732
0
0
20,018
17,279
17,279
40,510
40,436
43,265
45,802
52,256
50,045
47,629
49,438
50,524
54,828
47,588
45,399
63,327
62,020
54,281
50,575
68,395
69,973
69,074
113,056
113,235
125,919
125,919113,235113,05669,07469,97368,39550,57554,28162,02063,32745,39947,58854,82850,52449,43847,62950,04552,25645,80243,26540,43640,51017,27917,27920,018004,732
   > Total Current Liabilities 
2,494
0
0
7,652
5,185
5,185
13,722
15,108
14,112
18,065
22,893
19,500
18,440
19,175
22,013
26,988
21,779
21,427
36,314
39,956
34,087
32,386
32,313
34,801
24,672
22,111
23,383
27,339
27,33923,38322,11124,67234,80132,31332,38634,08739,95636,31421,42721,77926,98822,01319,17518,44019,50022,89318,06514,11215,10813,7225,1855,1857,652002,494
       Short-term Debt 
0
0
0
10,521
10,508
10,508
0
0
2,574
2,890
1,642
2,505
3,421
4,240
5,069
5,874
6,075
6,171
7,458
7,483
6,886
7,174
6,325
5,294
4,628
4,838
6,003
6,904
6,9046,0034,8384,6285,2946,3257,1746,8867,4837,4586,1716,0755,8745,0694,2403,4212,5051,6422,8902,5740010,50810,50810,521000
       Short Long Term Debt 
0
0
0
10,521
10,508
10,508
0
0
2,574
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,5740010,50810,50810,521000
       Accounts payable 
762
0
0
3,935
2,671
2,671
3,874
4,825
3,622
5,253
6,737
4,621
5,008
4,301
3,284
9,578
6,368
4,795
3,393
4,230
5,641
2,381
2,885
8,694
5,975
4,925
4,265
3,819
3,8194,2654,9255,9758,6942,8852,3815,6414,2303,3934,7956,3689,5783,2844,3015,0084,6216,7375,2533,6224,8253,8742,6712,6713,93500762
       Other Current Liabilities 
1,732
0
0
3,717
0
2,514
4,638
4,943
2,497
4,424
7,291
7,418
5,500
4,856
8,132
8,061
5,950
7,521
11,677
11,042
9,236
11,752
14,415
15,682
11,268
9,530
11,814
14,266
14,26611,8149,53011,26815,68214,41511,7529,23611,04211,6777,5215,9508,0618,1324,8565,5007,4187,2914,4242,4974,9434,6382,51403,717001,732
   > Long-term Liabilities 
0
0
0
12,366
0
12,094
26,788
25,328
29,153
27,737
29,363
30,545
29,189
30,263
28,511
27,840
25,809
23,972
27,013
22,064
20,194
18,189
36,082
35,172
44,402
90,945
89,852
98,580
98,58089,85290,94544,40235,17236,08218,18920,19422,06427,01323,97225,80927,84028,51130,26329,18930,54529,36327,73729,15325,32826,78812,094012,366000
       Long term Debt Total 
0
0
0
0
0
0
0
10,490
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,281
19,349
29,576
29,723
0
0
0029,72329,57619,34919,2810000000000000010,4900000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-10,521
-10,508
-10,508
0
0
17,104
16,919
19,432
20,985
20,101
22,258
20,791
19,225
17,619
16,176
19,844
18,936
18,689
17,800
16,752
15,673
14,575
60,824
59,430
57,727
57,72759,43060,82414,57515,67316,75217,80018,68918,93619,84416,17617,61919,22520,79122,25820,10120,98519,43216,91917,10400-10,508-10,508-10,521000
       Long-term Liabilities Other 
0
0
0
0
0
0
10,527
0
2
0
29,363
30,545
29,189
375
28,511
27,840
25,809
395
27,013
22,064
20,194
18,189
16,801
15,823
14,826
61,222
554
709
70955461,22214,82615,82316,80118,18920,19422,06427,01339525,80927,84028,51137529,18930,54529,36302010,527000000
       Deferred Long Term Liability 
0
0
0
0
0
0
16,261
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000016,261000000
> Total Stockholder Equity
41,689
-19,450
0
97,282
-59,655
78,672
72,691
149,122
132,222
182,378
156,395
134,344
115,389
96,228
71,984
166,739
199,351
178,825
207,955
216,086
189,191
163,378
136,847
170,781
140,878
109,567
73,982
51,850
51,85073,982109,567140,878170,781136,847163,378189,191216,086207,955178,825199,351166,73971,98496,228115,389134,344156,395182,378132,222149,12272,69178,672-59,65597,2820-19,45041,689
   Common Stock
1
0
0
1
2
14
2
16
16
17
17
17
17
17
17
18
18
18
20
20
20
20
20
22
22
22
22
22
22222222222020202020181818171717171717161621421001
   Retained Earnings Total Equity00-590,309-555,053-521,071-489,781-459,815-430,300-401,384-371,615-343,497-318,379-326,302-299,135-273,062-247,194-220,988-193,2840-144,5640-109,063000000
   Accumulated Other Comprehensive Income 
0
0
0
-74
0
-31
-5
-85
67
76
31
24
-20
50
5
0
-3
14
7
-73
-391
-410
-281
-80
-52
-125
-52
3
3-52-125-52-80-281-410-391-73714-30550-2024317667-85-5-310-74000
   Capital Surplus 
0
0
0
0
0
0
3,885
275,593
276,703
348,021
349,631
355,291
362,586
369,223
371,097
493,023
517,715
522,290
579,543
617,523
619,862
623,583
626,889
691,910
695,961
699,979
0
0
00699,979695,961691,910626,889623,583619,862617,523579,543522,290517,715493,023371,097369,223362,586355,291349,631348,021276,703275,5933,885000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
-3
0
0
2,045
-31
169,164
3,885
275,593
276,703
348,021
349,631
355,291
362,586
369,223
371,097
493,023
517,715
522,290
579,543
617,523
619,862
623,583
626,889
691,910
695,961
699,979
702,755
711,386
711,386702,755699,979695,961691,910626,889623,583619,862617,523579,543522,290517,715493,023371,097369,223362,586355,291349,631348,021276,703275,5933,885169,164-312,04500-3



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,331
Cost of Revenue-7,591
Gross Profit-6,260-6,260
 
Operating Income (+$)
Gross Profit-6,260
Operating Expense-148,374
Operating Income-154,634-154,634
 
Operating Expense (+$)
Research Development127,182
Selling General Administrative28,783
Selling And Marketing Expenses-7,591
Operating Expense148,374148,374
 
Net Interest Income (+$)
Interest Income5,637
Interest Expense-4,036
Other Finance Cost-534
Net Interest Income2,135
 
Pretax Income (+$)
Operating Income-154,634
Net Interest Income2,135
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-138,490-170,778
EBIT - interestExpense = -158,670
-138,490
-134,454
Interest Expense4,036
Earnings Before Interest and Taxes (EBIT)-154,634-134,454
Earnings Before Interest and Taxes (EBITDA)-147,043
 
After tax Income (+$)
Income Before Tax-138,490
Tax Provision-0
Net Income From Continuing Ops-138,962-138,490
Net Income-138,490
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses155,965
Total Other Income/Expenses Net16,144-2,135
 

Technical Analysis of Gritstone Oncology Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gritstone Oncology Inc. The general trend of Gritstone Oncology Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gritstone Oncology Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gritstone Oncology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.1393 < 1.26 < 1.47.

The bearish price targets are: .

Tweet this
Gritstone Oncology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gritstone Oncology Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gritstone Oncology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Moving Average Convergence/Divergence (MACD) ChartGritstone Oncology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gritstone Oncology Inc. The current adx is .

Gritstone Oncology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Relative Strength Index (RSI) ChartGritstone Oncology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Stochastic Oscillator ChartGritstone Oncology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Commodity Channel Index (CCI) ChartGritstone Oncology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Chande Momentum Oscillator (CMO) ChartGritstone Oncology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Williams %R ChartGritstone Oncology Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Average True Range (ATR) ChartGritstone Oncology Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily On-Balance Volume (OBV) ChartGritstone Oncology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gritstone Oncology Inc.

Gritstone Oncology Inc Daily Money Flow Index (MFI) ChartGritstone Oncology Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gritstone Oncology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Gritstone Oncology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gritstone Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.742
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gritstone Oncology Inc with someone you think should read this too:
  • Are you bullish or bearish on Gritstone Oncology Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gritstone Oncology Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gritstone Oncology Inc

I send you an email if I find something interesting about Gritstone Oncology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Gritstone Oncology Inc.

Receive notifications about Gritstone Oncology Inc in your mailbox!